18F-FPRGD2 PET/CT imaging of integrin αvβ3 in renal carcinomas: Correlation with histopathology

Journal of Nuclear Medicine

Volumn 56, Issue 3, 2015, Pages 361-364

  Withofs, Nadia ^a   Signolle, Nicolas ^b   Somja, Joan ^a   Lovinfosse, Pierre ^a   Nzaramba, Eugène Mutijima ^a   Mievis, Frédéric ^b   Giacomelli, Fabrice ^b   Waltregny, David ^a   Cataldo, Didier ^b   Gambhir, Sanjiv S ^c   Hustinx, Roland ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b UNIVERSITY OF LIÈGE   (Belgium)

^c STANFORD UNIVERSITY   (United States)

Author keywords

Angiogenesis; Integrin; PET; Renal cancer; RGD

Indexed keywords

CD31 ANTIGEN; ENDOGLIN; FPRGD2 F 18; KI 67 ANTIGEN; PLACENTAL GROWTH FACTOR; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2; VITRONECTIN RECEPTOR; 4-FLUOROBENOZYL-GLUTAMYL-CYCLO(ARGINYL-GLYCYL-ASPARTYL-TYROSYL-LYSYL)2; CYCLOPEPTIDE; MACROGOL DERIVATIVE;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER STAGING; CANCER TISSUE; CARCINOGENESIS; CLEAR CELL CARCINOMA; CLINICAL ARTICLE; CLINICAL TRIAL (TOPIC); COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; DRUG UPTAKE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; KIDNEY CARCINOMA; KIDNEY MASS; KIDNEY PAPILLA CARCINOMA; KIDNEY SURGERY; MALE; NEPHRECTOMY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR VASCULARIZATION; CELL MEMBRANE; CHEMISTRY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC USE; KIDNEY TUMOR; METABOLISM; MICROCIRCULATION; MIDDLE AGED; NEOVASCULARIZATION (PATHOLOGY); NUCLEAR MEDICINE; RADIOGRAPHY; SCINTISCANNING; TREATMENT OUTCOME;

AGED; ANTIGENS, CD31; CARCINOMA, RENAL CELL; CELL MEMBRANE; FEMALE; HUMANS; INTEGRIN ALPHAVBETA3; KIDNEY NEOPLASMS; MALE; MICROCIRCULATION; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; NUCLEAR MEDICINE; PEPTIDES, CYCLIC; POLYETHYLENE GLYCOLS; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84928167711     PISSN: 01615505     EISSN: 2159662X     Source Type: Journal    
DOI: 10.2967/jnumed.114.149021     Document Type: Article

References (14)

1. 18F-FPRGD2): synthesis and microPET imaging of alphavbeta3 integrin expression. Eur J Nucl Med Mol Imaging. 2007;34:1823-1831.
2. 18F] SFB) with RGD peptide using a GE FASTlab synthesizer. Mol Imaging Biol. 2011;13:1088-1095.
3. 18F]galacto-RGD. PLoS Med. 2005;2:e70.
4. 18F-FRGD2. J Nucl Med. 2006;47:113-121.
5. vbeta3 expression in man. Clin Cancer Res. 2006;12:3942-3949.
6. 18F] galacto-RGD positron emission tomography. Neuro Oncol. 2009;11:861-870.
7. 18F-alfatide in lung cancer patients using a new lyophilized kit for rapid radiofluorination. J Nucl Med. 2013;54:691-698.
8. Desgrosellier JS, Cheresh DA. Integrins in cancer: biological implications and therapeutic opportunities. Nat Rev Cancer. 2010;10:9-22.
9. Ducassou A, Uro-Coste E, Verrelle P, et al. alphavbeta3 integrin and fibroblast growth factor receptor 1 (FGFR1): prognostic factors in a phase I-II clinical trial associating continuous administration of tipifarnib with radiotherapy for patients with newly diagnosed glioblastoma. Eur J Cancer. 2013;49:2161-2169.
10. Schittenhelm J, Schwab EI, Sperveslage J, et al. Longitudinal expression analysis of alphav integrins in human gliomas reveals upregulation of integrin alphavbeta3 as a negative prognostic factor. J Neuropathol Exp Neurol. 2013;72:194-210.
11. Gayed BA, Youssef RF, Bagrodia A, et al. Ki67 is an independent predictor of oncological outcomes in patients with localized clear-cell renal cell carcinoma. BJU Int. 2014;113:668-673.
12. Vogetseder A, Thies S, Ingold B, et al. alphav-integrin isoform expression in primary human tumors and brain metastases. Int J Cancer. 2013;133:2362-2371.
13. Rabb H, Barroso-Vicens E, Adams R, Pow-Sang J, Ramirez G. Alpha-V/beta-3 and alpha-V/beta-5 integrin distribution in neoplastic kidney. Am J Nephrol. 1996;16:402-408.
14. 18F]fluciclatide in the in vivo evaluation of human melanoma and renal tumors expressing alphavbeta 3 and alpha vbeta 5 integrins. Eur J Nucl Med Mol Imaging. 2014;41:1879-1888.